FDA approves labeling changes for six menopausal hormone therapy products
Regulatory NewsJoanne S. Eglovitch
Advertising, Promotion and LabelingPharmaceuticalsRegulatory Intelligence/PolicyRegulatory writing/documentationUnited StatesUS Food and Drug Administration (FDA)